First-in-Human Trial Uses Laser Light to Attack Inoperable Pancreatic Tumors
A first-in-human phase 1 trial at UCI Health is using padeliporfin vascular-targeted photodynamic therapy to destroy pancreatic tumors encasing major ...
Tag: ImPact Biotech
